Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-25

Clinical Trial Update: Meropenem Dosage Strategy Based on PPK Model [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating a population pharmacokinetic-based dosing strategy for meropenem in lower respiratory tract infections; results have been post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Meropenem (Meropenem)

Snippet

Sponsor: Qingtao Zhou | Conditions: Lower Respiratory Tract Infection | Phase 4 | Status: COMPLETED | Results posted: 2016-02-25